Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
WHO prequalifies first generic hepatitis C medicine and first HIV self-test

WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories Ltd., India.

Published
11 hours ago
From
World Health Organization
US regulator approves Gilead's Vosevi combo pill for hepatitis C retreatment

On 18 July the US Food and Drug Administration (FDA) approved Gilead Sciences' Vosevi, a new once-daily combination pill containing sofosbuvir, velpatasvir, and voxilaprevir. Vosevi

Published
19 July 2017
By
Liz Highleyman
The 2017 Pipeline Report

Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Published
19 July 2017
From
Treatment Action Group
Targeting MSM with HIV: Treatment as Prevention in the Netherlands

As part of Dutch HIV guidelines, all individuals with HIV are screened for hepatitis C. Anne Boerekamps, MD, of Erasmus University Medical Center in Rotterdam, the Netherlands, spoke with HCV Next about the Dutch approach, the relevant data, and other topics associated with screening and treating MSM.

Published
18 July 2017
From
Healio Hepatology
Contaminated blood scandal: Theresa May orders inquiry

Inquiry to look into deaths of 2,400 people after thousands were infected with hepatitis C and HIV in 1970s and 80s.

Published
11 July 2017
From
The Guardian
Curing hepatitis C improves diabetes control

Curing hepatitis C infection with direct-acting antiviral treatment improves diabetes control in people with more severe type 2 diabetes, a review of patients treated in

Published
06 July 2017
By
Keith Alcorn
Australian NSP Survey National Data Report 2012 – 2016

Nationally, the proportion of respondents who reported recent (last 12 months) initiation of HCV treatment was low and stable at 1-3% between 2011-2015, but increased significantly to 22% in 2016, with substantial increases observed in all jurisdictions.

Published
04 July 2017
From
Kirby Institute
Hepatitis C and women of childbearing age

About half of these young people who are injecting drugs are women of childbearing age. And although sexual transmission or transmission of HCV from infected household items is rare, it can happen. And women whose partners inject drugs are also at risk for exposure.

Published
04 July 2017
From
Harvard Health Blog
San Francisco task force releases first hepatitis C estimates

End Hep C SF, a consortium of public health workers, medical providers, advocates and people living with hepatitis C, has released the first-ever estimate of the number

Published
03 July 2017
By
Liz Highleyman
Charity calls for new focus to combat Hep C infections in Scotland

A charity has called for greater efforts to eliminate Hepatitis C (HCV) from Scotland. There are about 37,000 people living with the virus - but campaigners say as many again are undiagnosed.

Published
27 June 2017
From
BBC
← First12345...177Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.